Recombinant Human TLR3

Leinco Technologies
Product Code: LEI-T526
Product Group: Recombinant Proteins
CodeSizePrice
LEI-T526-50ug50 ug£580.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Human
Regulatory Status: RUO
Shipping:
Ambient
Storage:
This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions.

Further Information

Format:
This recombinant protein was 0.2 um filtered and lyophilized from modified Dulbecco?s phosphate buffered saline (1X PBS) pH 7.2 ? 7.3 with no calcium, magnesium, or preservatives.
Formulation:
This recombinant protein was 0.2 um filtered and lyophilized from modified Dulbecco?s phosphate buffered saline (1X PBS) pH 7.2 ? 7.3 with no calcium, magnesium, or preservatives.
Long Description:
Toll-like receptor-3 (TLR-3), also known as CD283, is a type I transmembrane glycoprotein and member of the TLR family which play a fundamental role in pathogen recognition and activation of innate immunity (1). They recognize pathogen associated molecular patterns (PAMPs) that are expressed on infectious agents and mediate the production of cytokines necessary for the development of effective immunity (2). TLR-3 is expressed primarily in dendritic cells of the placenta and pancreas where it can reside on both sides of the plasma membrane and in the endosomal compartment of the cells. It is also expressed in macrophages, micoglia and astrocytes, and is upregulated by IFNβ and LPS (4). TLR-3 recognizes dsRNA associated with viral infection, and induces the activation of NFκB and the production of type I interferons (5). It also signals the p53 pathway to trigger apoptosis in cells infected with dsRNA viruses.
NCBI Gene:
7098
Purity:
>95% by SDS-PAGE and analyzed by silver stain.
Target:
TLR3

References

1. Hopkins, PA. et al. (2005) Clin. Exp. Immunol. 140:395 2. Schroder, M. et al. (2005) Trends Immunol. 26:462 3. Farina, C. et al. (2005) J. Neuroimmunol. 159:12 4. de Bouteiller, O. et al. (2005) J. Biol. Chem. 280:38133 5. Takaki, H. et al. (2009) Eur. J. Immunol. 39:3469